close
Solutions
keyboard_arrow_downServices
keyboard_arrow_downSupport & Resources
keyboard_arrow_downCompany
keyboard_arrow_downContact
Randox Health search
The RIQAS Cytokines EQA Programme is a comprehensive EQA scheme, suitable for monitoring the performance of 12 different Cytokines.
Lyophilised material for enhanced stability
Submit results and view reports online via RIQAS.Net
World's largest EQA scheme ensuring peer groups are maximised
Monthly reporting for earlier identification of test system errors
Cycle Starts - October 2026
Not Accredited
Get in touch to discover more
To find out more about RIQAS EQA or to get in touch with your local Randox Representative, enquire now.
| Description | Frequency | Size | Cat No | |
|---|---|---|---|---|
| Cytokines | Monthly | 12 x 1 ml | RQ9195 |
Parameters
- Epidermal Growth Factor (EGF)*
- Interleukin – 4 (IL-4)*
- Interferon gamma (INF-Y)*
- Interleukin – 1 alpha (IL-1α)*
- Interleukin – 6 (IL-6)
- Monocyte Chemoattractant Protein -1 (MCP-1)*
- Interleukin – 1 beta (IL-1β)*
- Interleukin – 8 (IL-8)*
- Tumour Necrosis Factor alpha (TNF-α)*
- Interleukin – 2 (IL-2)*
- Interleukin – 10 (IL-10)*
- Vascular Endothelial Growth Factor (VEGF)*
* Pilot Study Ongoing.
Please note, product availability may vary country to country.
Related RIQAS EQA Programmes
Immunoassay
Immunoassay Speciality 1
Immunoassay Speciality 2
